Evidence map›Paper›PMID 37890465›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

The PERK Branch of the Unfolded Protein Response Safeguards Protein Homeostasis and Mesendoderm Specification of Human Pluripotent Stem Cells.

Fang Liu, Zhun Liu, Weisheng Cheng, Qingquan Zhao, Xinyu Zhang, He Zhang, Miao Yu, He Xu, Yichen Gao, Qianrui Jiang and 6 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Fang LiuAdvanced Medical Technology Center, Zhongshan School of Medicine and the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, P. R. China.
Zhun LiuAdvanced Medical Technology Center, Zhongshan School of Medicine and the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, P. R. China.
Weisheng ChengPrenatal Diagnosis Center, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, P. R. China.
Qingquan ZhaoAdvanced Medical Technology Center, Zhongshan School of Medicine and the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, P. R. China.
Xinyu ZhangAdvanced Medical Technology Center, Zhongshan School of Medicine and the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, P. R. China.
He ZhangAdvanced Medical Technology Center, Zhongshan School of Medicine and the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, P. R. China.
Miao YuAdvanced Medical Technology Center, Zhongshan School of Medicine and the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, P. R. China.
He XuAdvanced Medical Technology Center, Zhongshan School of Medicine and the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, P. R. China.
Yichen GaoAdvanced Medical Technology Center, Zhongshan School of Medicine and the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, P. R. China.
Qianrui JiangAdvanced Medical Technology Center, Zhongshan School of Medicine and the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, P. R. China.
Guojun ShiGuangzhou Municipal Key Laboratory of Mechanistic and Translational Obesity Research, Guangdong Provincial Key Laboratory of Diabetology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangdong, 510080, P. R. China.
Likun WangNational Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, P. R. China.
Shanshan GuAdvanced Medical Technology Center, Zhongshan School of Medicine and the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, P. R. China.
Jia WangSchool of Health and Life Sciences, University of Health and Rehabilitation Sciences, Shandong, 266071, China.
Nan CaoAdvanced Medical Technology Center, Zhongshan School of Medicine and the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, P. R. China.ORCID 0000-0002-1660-4728
Zhongyan ChenAdvanced Medical Technology Center, Zhongshan School of Medicine and the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, P. R. China.ORCID 0000-0002-1005-813X
Sun Yat-sen University · CNChinese Academy of Sciences · CNShandong University · CN

Funding

CAS Youth Interdisciplinary Team JCTD-2021-07National Key Research and Development Program of China 2021YFA1102500National Natural Science Foundation of China 32200685National Natural Science Foundation of China 82061148011National Natural Science Foundation of China 92057113National Natural Science Foundation of China 92268105Natural Science Foundation of Guangdong Province 2021A1515012489Natural Science Foundation of Guangdong Province 2022A1515011819Qingdao Municipal Science and Technology Bureau 23-2-8-smjk-11-nsh
6 · The paper itself

Abstract

Cardiac development involves large-scale rearrangements of the proteome. How the developing cardiac cells maintain the integrity of the proteome during the rapid lineage transition remains unclear. Here it is shown that proteotoxic stress visualized by the misfolded and/or aggregated proteins appears during early cardiac differentiation of human pluripotent stem cells and is resolved by activation of the PERK branch of unfolded protein response (UPR). PERK depletion increases misfolded and/or aggregated protein accumulation, leading to pluripotency exit defect and impaired mesendoderm specification of human pluripotent stem cells. Mechanistically, it is found that PERK safeguards mesendoderm specification through its conserved downstream effector ATF4, which subsequently activates a novel transcriptional target WARS1, to cope with the differentiation-induced proteotoxic stress. The results indicate that protein quality control represents a previously unrecognized core component of the cardiogenic regulatory network. Broadly, these findings provide a framework for understanding how UPR is integrated into the developmental program by activating the PERK-ATF4-WARS1 axis.

Indexed as

eIF-2 KinasePluripotent Stem CellsHumansProteomeProteostasisUnfolded Protein ResponseEIF2AK3 protein, humaneIF-2 KinaseProteomehuman pluripotent stem cellsmesendoderm specificationPERKproteostasisunfolded protein response

Identifiers

PMID37890465
PMCPMC10724406
OpenAlexW4387968514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.